<!-- html table generated in R 3.4.4 by xtable 1.8-2 package -->
<!-- Sun Jun 10 12:46:23 2018 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0048875 </td> <td align="right"> 0.00 </td> <td align="right"> 24.75 </td> <td align="right"> 0.26 </td> <td align="right">   4 </td> <td align="right">  10 </td> <td> chemical homeostasis within a tissue </td> <td> EPAS1, ABCA12, HOMER2, HOMER1 </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0006554 </td> <td align="right"> 0.00 </td> <td align="right"> 12.34 </td> <td align="right"> 0.32 </td> <td align="right">   3 </td> <td align="right">  12 </td> <td> lysine catabolic process </td> <td> CRYM, DLST, GCDH </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:0010457 </td> <td align="right"> 0.00 </td> <td align="right"> 12.34 </td> <td align="right"> 0.32 </td> <td align="right">   3 </td> <td align="right">  12 </td> <td> centriole-centriole cohesion </td> <td> KIF3A, DCTN1, CNTLN </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:0002115 </td> <td align="right"> 0.00 </td> <td align="right"> 11.11 </td> <td align="right"> 0.34 </td> <td align="right">   3 </td> <td align="right">  13 </td> <td> store-operated calcium entry </td> <td> ORAI1, ORAI3, HOMER1 </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:0006553 </td> <td align="right"> 0.00 </td> <td align="right"> 11.11 </td> <td align="right"> 0.34 </td> <td align="right">   3 </td> <td align="right">  13 </td> <td> lysine metabolic process </td> <td> CRYM, DLST, GCDH </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0007252 </td> <td align="right"> 0.01 </td> <td align="right"> 10.10 </td> <td align="right"> 0.37 </td> <td align="right">   3 </td> <td align="right">  14 </td> <td> I-kappaB phosphorylation </td> <td> AKT1, TLR7, MAP3K7 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0007210 </td> <td align="right"> 0.00 </td> <td align="right"> 9.89 </td> <td align="right"> 0.50 </td> <td align="right">   4 </td> <td align="right">  19 </td> <td> serotonin receptor signaling pathway </td> <td> HTR2B, HTR5A, HTR6, HTR7 </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0098664 </td> <td align="right"> 0.00 </td> <td align="right"> 9.89 </td> <td align="right"> 0.50 </td> <td align="right">   4 </td> <td align="right">  19 </td> <td> G-protein coupled serotonin receptor signaling pathway </td> <td> HTR2B, HTR5A, HTR6, HTR7 </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0016601 </td> <td align="right"> 0.00 </td> <td align="right"> 9.32 </td> <td align="right"> 0.79 </td> <td align="right">   6 </td> <td align="right">  30 </td> <td> Rac protein signal transduction </td> <td> EPS8, AUTS2, BRK1, RHOU, ELMO1, ARHGAP44 </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0052695 </td> <td align="right"> 0.01 </td> <td align="right"> 9.26 </td> <td align="right"> 0.40 </td> <td align="right">   3 </td> <td align="right">  15 </td> <td> cellular glucuronidation </td> <td> UGT1A8, UGT1A9, UGT2B17 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:0035584 </td> <td align="right"> 0.01 </td> <td align="right"> 7.93 </td> <td align="right"> 0.45 </td> <td align="right">   3 </td> <td align="right">  17 </td> <td> calcium-mediated signaling using intracellular calcium source </td> <td> BCAP31, PRNP, HOMER2 </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:0060644 </td> <td align="right"> 0.01 </td> <td align="right"> 7.93 </td> <td align="right"> 0.45 </td> <td align="right">   3 </td> <td align="right">  17 </td> <td> mammary gland epithelial cell differentiation </td> <td> CEBPB, ERBB4, AKT1 </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0010765 </td> <td align="right"> 0.00 </td> <td align="right"> 7.43 </td> <td align="right"> 0.79 </td> <td align="right">   5 </td> <td align="right">  30 </td> <td> positive regulation of sodium ion transport </td> <td> DMD, AKT1, GLRX, FXYD1, SCN5A </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:1902307 </td> <td align="right"> 0.01 </td> <td align="right"> 7.40 </td> <td align="right"> 0.48 </td> <td align="right">   3 </td> <td align="right">  18 </td> <td> positive regulation of sodium ion transmembrane transport </td> <td> DMD, GLRX, FXYD1 </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0007097 </td> <td align="right"> 0.01 </td> <td align="right"> 6.94 </td> <td align="right"> 0.50 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> nuclear migration </td> <td> TMEM201, SYNE2, NTN1 </td> </tr>
  <tr> <td> 16 </td> <td align="center"> GO:0009068 </td> <td align="right"> 0.01 </td> <td align="right"> 6.94 </td> <td align="right"> 0.50 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> aspartate family amino acid catabolic process </td> <td> CRYM, DLST, GCDH </td> </tr>
  <tr> <td> 17 </td> <td align="center"> GO:0009219 </td> <td align="right"> 0.01 </td> <td align="right"> 6.94 </td> <td align="right"> 0.50 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> pyrimidine deoxyribonucleotide metabolic process </td> <td> DCTD, UNG, MBD4 </td> </tr>
  <tr> <td> 18 </td> <td align="center"> GO:0034162 </td> <td align="right"> 0.01 </td> <td align="right"> 6.94 </td> <td align="right"> 0.50 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> toll-like receptor 9 signaling pathway </td> <td> IRAK4, TLR7, NR1H4 </td> </tr>
  <tr> <td> 19 </td> <td align="center"> GO:0006063 </td> <td align="right"> 0.02 </td> <td align="right"> 6.53 </td> <td align="right"> 0.53 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> uronic acid metabolic process </td> <td> UGT1A8, UGT1A9, UGT2B17 </td> </tr>
  <tr> <td> 20 </td> <td align="center"> GO:0019585 </td> <td align="right"> 0.02 </td> <td align="right"> 6.53 </td> <td align="right"> 0.53 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> glucuronate metabolic process </td> <td> UGT1A8, UGT1A9, UGT2B17 </td> </tr>
  <tr> <td> 21 </td> <td align="center"> GO:0007205 </td> <td align="right"> 0.01 </td> <td align="right"> 6.45 </td> <td align="right"> 0.71 </td> <td align="right">   4 </td> <td align="right">  27 </td> <td> protein kinase C-activating G-protein coupled receptor signaling pathway </td> <td> F2R, HCRT, HTR2B, DGKD </td> </tr>
  <tr> <td> 22 </td> <td align="center"> GO:0002755 </td> <td align="right"> 0.00 </td> <td align="right"> 6.41 </td> <td align="right"> 0.90 </td> <td align="right">   5 </td> <td align="right">  34 </td> <td> MyD88-dependent toll-like receptor signaling pathway </td> <td> IRF1, MAP3K1, IRAK4, TLR7, MAP3K7 </td> </tr>
  <tr> <td> 23 </td> <td align="center"> GO:1903727 </td> <td align="right"> 0.00 </td> <td align="right"> 6.21 </td> <td align="right"> 1.11 </td> <td align="right">   6 </td> <td align="right">  42 </td> <td> positive regulation of phospholipid metabolic process </td> <td> EPHA8, FGF2, FGFR3, HTR2B, PDGFRA, NR1H4 </td> </tr>
  <tr> <td> 24 </td> <td align="center"> GO:0071379 </td> <td align="right"> 0.02 </td> <td align="right"> 6.17 </td> <td align="right"> 0.56 </td> <td align="right">   3 </td> <td align="right">  21 </td> <td> cellular response to prostaglandin stimulus </td> <td> AKR1C2, AKT1, GNB1 </td> </tr>
  <tr> <td> 25 </td> <td align="center"> GO:0015949 </td> <td align="right"> 0.01 </td> <td align="right"> 5.93 </td> <td align="right"> 0.77 </td> <td align="right">   4 </td> <td align="right">  29 </td> <td> nucleobase-containing small molecule interconversion </td> <td> DCTD, GLRX, GUK1, TXNRD1 </td> </tr>
  <tr> <td> 26 </td> <td align="center"> GO:0043552 </td> <td align="right"> 0.01 </td> <td align="right"> 5.93 </td> <td align="right"> 0.77 </td> <td align="right">   4 </td> <td align="right">  29 </td> <td> positive regulation of phosphatidylinositol 3-kinase activity </td> <td> EPHA8, FGF2, FGFR3, PDGFRA </td> </tr>
  <tr> <td> 27 </td> <td align="center"> GO:0030539 </td> <td align="right"> 0.02 </td> <td align="right"> 5.84 </td> <td align="right"> 0.58 </td> <td align="right">   3 </td> <td align="right">  22 </td> <td> male genitalia development </td> <td> HOXD13, HSD17B3, PDGFRA </td> </tr>
  <tr> <td> 28 </td> <td align="center"> GO:0009394 </td> <td align="right"> 0.01 </td> <td align="right"> 5.70 </td> <td align="right"> 0.79 </td> <td align="right">   4 </td> <td align="right">  30 </td> <td> 2'-deoxyribonucleotide metabolic process </td> <td> DCTD, GUK1, UNG, MBD4 </td> </tr>
  <tr> <td> 29 </td> <td align="center"> GO:0010955 </td> <td align="right"> 0.00 </td> <td align="right"> 5.63 </td> <td align="right"> 1.01 </td> <td align="right">   5 </td> <td align="right">  38 </td> <td> negative regulation of protein processing </td> <td> CR1, PRNP, CHAC1, BIRC7, BCL2L12 </td> </tr>
  <tr> <td> 30 </td> <td align="center"> GO:1903318 </td> <td align="right"> 0.00 </td> <td align="right"> 5.63 </td> <td align="right"> 1.01 </td> <td align="right">   5 </td> <td align="right">  38 </td> <td> negative regulation of protein maturation </td> <td> CR1, PRNP, CHAC1, BIRC7, BCL2L12 </td> </tr>
  <tr> <td> 31 </td> <td align="center"> GO:0042573 </td> <td align="right"> 0.02 </td> <td align="right"> 5.55 </td> <td align="right"> 0.61 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> retinoic acid metabolic process </td> <td> CYP26C1, UGT1A8, UGT1A9 </td> </tr>
  <tr> <td> 32 </td> <td align="center"> GO:0051647 </td> <td align="right"> 0.02 </td> <td align="right"> 5.55 </td> <td align="right"> 0.61 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> nucleus localization </td> <td> TMEM201, SYNE2, NTN1 </td> </tr>
  <tr> <td> 33 </td> <td align="center"> GO:0034080 </td> <td align="right"> 0.00 </td> <td align="right"> 5.46 </td> <td align="right"> 1.03 </td> <td align="right">   5 </td> <td align="right">  39 </td> <td> CENP-A containing nucleosome assembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, CENPL </td> </tr>
  <tr> <td> 34 </td> <td align="center"> GO:0061641 </td> <td align="right"> 0.00 </td> <td align="right"> 5.46 </td> <td align="right"> 1.03 </td> <td align="right">   5 </td> <td align="right">  39 </td> <td> CENP-A containing chromatin organization </td> <td> CENPA, CENPC, ITGB3BP, CENPI, CENPL </td> </tr>
  <tr> <td> 35 </td> <td align="center"> GO:0019692 </td> <td align="right"> 0.01 </td> <td align="right"> 5.30 </td> <td align="right"> 0.85 </td> <td align="right">   4 </td> <td align="right">  32 </td> <td> deoxyribose phosphate metabolic process </td> <td> DCTD, GUK1, UNG, MBD4 </td> </tr>
  <tr> <td> 36 </td> <td align="center"> GO:0090218 </td> <td align="right"> 0.01 </td> <td align="right"> 5.30 </td> <td align="right"> 0.85 </td> <td align="right">   4 </td> <td align="right">  32 </td> <td> positive regulation of lipid kinase activity </td> <td> EPHA8, FGF2, FGFR3, PDGFRA </td> </tr>
  <tr> <td> 37 </td> <td align="center"> GO:2000008 </td> <td align="right"> 0.01 </td> <td align="right"> 5.30 </td> <td align="right"> 0.85 </td> <td align="right">   4 </td> <td align="right">  32 </td> <td> regulation of protein localization to cell surface </td> <td> ERBB4, RAB11FIP5, ABCA12, GBF1 </td> </tr>
  <tr> <td> 38 </td> <td align="center"> GO:0043551 </td> <td align="right"> 0.00 </td> <td align="right"> 5.16 </td> <td align="right"> 1.09 </td> <td align="right">   5 </td> <td align="right">  41 </td> <td> regulation of phosphatidylinositol 3-kinase activity </td> <td> EPHA8, FGF2, FGFR3, PDGFRA, KLF4 </td> </tr>
  <tr> <td> 39 </td> <td align="center"> GO:0010863 </td> <td align="right"> 0.01 </td> <td align="right"> 5.11 </td> <td align="right"> 0.87 </td> <td align="right">   4 </td> <td align="right">  33 </td> <td> positive regulation of phospholipase C activity </td> <td> FGF2, HTR2B, ITK, PDGFRA </td> </tr>
  <tr> <td> 40 </td> <td align="center"> GO:0072529 </td> <td align="right"> 0.01 </td> <td align="right"> 5.11 </td> <td align="right"> 0.87 </td> <td align="right">   4 </td> <td align="right">  33 </td> <td> pyrimidine-containing compound catabolic process </td> <td> APOBEC3A, NT5E, UNG, MBD4 </td> </tr>
  <tr> <td> 41 </td> <td align="center"> GO:0006336 </td> <td align="right"> 0.00 </td> <td align="right"> 5.07 </td> <td align="right"> 1.32 </td> <td align="right">   6 </td> <td align="right">  50 </td> <td> DNA replication-independent nucleosome assembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, IPO4, CENPL </td> </tr>
  <tr> <td> 42 </td> <td align="center"> GO:0043550 </td> <td align="right"> 0.00 </td> <td align="right"> 5.07 </td> <td align="right"> 1.32 </td> <td align="right">   6 </td> <td align="right">  50 </td> <td> regulation of lipid kinase activity </td> <td> EPHA8, FGF2, FGFR3, PDGFRA, RBL2, KLF4 </td> </tr>
  <tr> <td> 43 </td> <td align="center"> GO:0005979 </td> <td align="right"> 0.03 </td> <td align="right"> 5.05 </td> <td align="right"> 0.66 </td> <td align="right">   3 </td> <td align="right">  25 </td> <td> regulation of glycogen biosynthetic process </td> <td> AKT1, ESRRB, GSK3A </td> </tr>
  <tr> <td> 44 </td> <td align="center"> GO:0010962 </td> <td align="right"> 0.03 </td> <td align="right"> 5.05 </td> <td align="right"> 0.66 </td> <td align="right">   3 </td> <td align="right">  25 </td> <td> regulation of glucan biosynthetic process </td> <td> AKT1, ESRRB, GSK3A </td> </tr>
  <tr> <td> 45 </td> <td align="center"> GO:1902751 </td> <td align="right"> 0.03 </td> <td align="right"> 5.05 </td> <td align="right"> 0.66 </td> <td align="right">   3 </td> <td align="right">  25 </td> <td> positive regulation of cell cycle G2/M phase transition </td> <td> CCND1, CDC7, CDC25A </td> </tr>
  <tr> <td> 46 </td> <td align="center"> GO:0034724 </td> <td align="right"> 0.00 </td> <td align="right"> 4.96 </td> <td align="right"> 1.35 </td> <td align="right">   6 </td> <td align="right">  51 </td> <td> DNA replication-independent nucleosome organization </td> <td> CENPA, CENPC, ITGB3BP, CENPI, IPO4, CENPL </td> </tr>
  <tr> <td> 47 </td> <td align="center"> GO:0009262 </td> <td align="right"> 0.01 </td> <td align="right"> 4.94 </td> <td align="right"> 0.90 </td> <td align="right">   4 </td> <td align="right">  34 </td> <td> deoxyribonucleotide metabolic process </td> <td> DCTD, GUK1, UNG, MBD4 </td> </tr>
  <tr> <td> 48 </td> <td align="center"> GO:0031055 </td> <td align="right"> 0.01 </td> <td align="right"> 4.89 </td> <td align="right"> 1.14 </td> <td align="right">   5 </td> <td align="right">  43 </td> <td> chromatin remodeling at centromere </td> <td> CENPA, CENPC, ITGB3BP, CENPI, CENPL </td> </tr>
  <tr> <td> 49 </td> <td align="center"> GO:0090199 </td> <td align="right"> 0.01 </td> <td align="right"> 4.89 </td> <td align="right"> 1.14 </td> <td align="right">   5 </td> <td align="right">  43 </td> <td> regulation of release of cytochrome c from mitochondria </td> <td> AKT1, LMNA, MFF, BAK1, PINK1 </td> </tr>
  <tr> <td> 50 </td> <td align="center"> GO:0001958 </td> <td align="right"> 0.03 </td> <td align="right"> 4.83 </td> <td align="right"> 0.69 </td> <td align="right">   3 </td> <td align="right">  26 </td> <td> endochondral ossification </td> <td> COL13A1, FGFR3, ALPL </td> </tr>
  <tr> <td> 51 </td> <td align="center"> GO:0036075 </td> <td align="right"> 0.03 </td> <td align="right"> 4.83 </td> <td align="right"> 0.69 </td> <td align="right">   3 </td> <td align="right">  26 </td> <td> replacement ossification </td> <td> COL13A1, FGFR3, ALPL </td> </tr>
  <tr> <td> 52 </td> <td align="center"> GO:0051693 </td> <td align="right"> 0.01 </td> <td align="right"> 4.78 </td> <td align="right"> 0.93 </td> <td align="right">   4 </td> <td align="right">  35 </td> <td> actin filament capping </td> <td> EPS8, SPTBN5, SPTBN1, SCIN </td> </tr>
  <tr> <td> 53 </td> <td align="center"> GO:1900274 </td> <td align="right"> 0.01 </td> <td align="right"> 4.78 </td> <td align="right"> 0.93 </td> <td align="right">   4 </td> <td align="right">  35 </td> <td> regulation of phospholipase C activity </td> <td> FGF2, HTR2B, ITK, PDGFRA </td> </tr>
  <tr> <td> 54 </td> <td align="center"> GO:0043486 </td> <td align="right"> 0.00 </td> <td align="right"> 4.75 </td> <td align="right"> 1.40 </td> <td align="right">   6 </td> <td align="right">  53 </td> <td> histone exchange </td> <td> CENPA, CENPC, ITGB3BP, CENPI, VPS72, CENPL </td> </tr>
  <tr> <td> 55 </td> <td align="center"> GO:0048806 </td> <td align="right"> 0.01 </td> <td align="right"> 4.64 </td> <td align="right"> 1.19 </td> <td align="right">   5 </td> <td align="right">  45 </td> <td> genitalia development </td> <td> HOXD13, HSD17B3, LRP2, PDGFRA, BAK1 </td> </tr>
  <tr> <td> 56 </td> <td align="center"> GO:0043537 </td> <td align="right"> 0.01 </td> <td align="right"> 4.63 </td> <td align="right"> 0.95 </td> <td align="right">   4 </td> <td align="right">  36 </td> <td> negative regulation of blood vessel endothelial cell migration </td> <td> HDAC5, FGF2, GDF2, KLF4 </td> </tr>
  <tr> <td> 57 </td> <td align="center"> GO:0045911 </td> <td align="right"> 0.03 </td> <td align="right"> 4.62 </td> <td align="right"> 0.71 </td> <td align="right">   3 </td> <td align="right">  27 </td> <td> positive regulation of DNA recombination </td> <td> UBE2B, UNG, WRN </td> </tr>
  <tr> <td> 58 </td> <td align="center"> GO:0048791 </td> <td align="right"> 0.03 </td> <td align="right"> 4.62 </td> <td align="right"> 0.71 </td> <td align="right">   3 </td> <td align="right">  27 </td> <td> calcium ion-regulated exocytosis of neurotransmitter </td> <td> SYT9, RIMS1, SYT17 </td> </tr>
  <tr> <td> 59 </td> <td align="center"> GO:0090200 </td> <td align="right"> 0.03 </td> <td align="right"> 4.62 </td> <td align="right"> 0.71 </td> <td align="right">   3 </td> <td align="right">  27 </td> <td> positive regulation of release of cytochrome c from mitochondria </td> <td> MFF, BAK1, PINK1 </td> </tr>
  <tr> <td> 60 </td> <td align="center"> GO:0030574 </td> <td align="right"> 0.00 </td> <td align="right"> 4.58 </td> <td align="right"> 1.69 </td> <td align="right">   7 </td> <td align="right">  64 </td> <td> collagen catabolic process </td> <td> COL4A3, COL12A1, COL13A1, COL19A1, ADAMTS14, CST3, COL25A1 </td> </tr>
  <tr> <td> 61 </td> <td align="center"> GO:0010518 </td> <td align="right"> 0.01 </td> <td align="right"> 4.53 </td> <td align="right"> 1.22 </td> <td align="right">   5 </td> <td align="right">  46 </td> <td> positive regulation of phospholipase activity </td> <td> FGF2, FGFR3, HTR2B, ITK, PDGFRA </td> </tr>
  <tr> <td> 62 </td> <td align="center"> GO:1903725 </td> <td align="right"> 0.00 </td> <td align="right"> 4.50 </td> <td align="right"> 1.72 </td> <td align="right">   7 </td> <td align="right">  65 </td> <td> regulation of phospholipid metabolic process </td> <td> EPHA8, FGF2, FGFR3, HTR2B, PDGFRA, KLF4, NR1H4 </td> </tr>
  <tr> <td> 63 </td> <td align="center"> GO:0071709 </td> <td align="right"> 0.04 </td> <td align="right"> 4.44 </td> <td align="right"> 0.74 </td> <td align="right">   3 </td> <td align="right">  28 </td> <td> membrane assembly </td> <td> CDH2, PACSIN2, SPTBN1 </td> </tr>
  <tr> <td> 64 </td> <td align="center"> GO:0030835 </td> <td align="right"> 0.02 </td> <td align="right"> 4.36 </td> <td align="right"> 1.01 </td> <td align="right">   4 </td> <td align="right">  38 </td> <td> negative regulation of actin filament depolymerization </td> <td> EPS8, SPTBN5, SPTBN1, SCIN </td> </tr>
  <tr> <td> 65 </td> <td align="center"> GO:0070873 </td> <td align="right"> 0.04 </td> <td align="right"> 4.27 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  29 </td> <td> regulation of glycogen metabolic process </td> <td> AKT1, ESRRB, GSK3A </td> </tr>
  <tr> <td> 66 </td> <td align="center"> GO:0097484 </td> <td align="right"> 0.04 </td> <td align="right"> 4.27 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  29 </td> <td> dendrite extension </td> <td> RIMS1, AUTS2, SYT17 </td> </tr>
  <tr> <td> 67 </td> <td align="center"> GO:0060193 </td> <td align="right"> 0.00 </td> <td align="right"> 4.21 </td> <td align="right"> 1.56 </td> <td align="right">   6 </td> <td align="right">  59 </td> <td> positive regulation of lipase activity </td> <td> FGF2, FGFR3, HTR2B, ITK, PDGFRA, LMF1 </td> </tr>
  <tr> <td> 68 </td> <td align="center"> GO:0016266 </td> <td align="right"> 0.01 </td> <td align="right"> 4.12 </td> <td align="right"> 1.32 </td> <td align="right">   5 </td> <td align="right">  50 </td> <td> O-glycan processing </td> <td> GALNT6, B3GNT6, GALNT2, GALNT9, B3GNT5 </td> </tr>
  <tr> <td> 69 </td> <td align="center"> GO:0034508 </td> <td align="right"> 0.01 </td> <td align="right"> 4.12 </td> <td align="right"> 1.32 </td> <td align="right">   5 </td> <td align="right">  50 </td> <td> centromere complex assembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, CENPL </td> </tr>
  <tr> <td> 70 </td> <td align="center"> GO:0015721 </td> <td align="right"> 0.04 </td> <td align="right"> 4.11 </td> <td align="right"> 0.79 </td> <td align="right">   3 </td> <td align="right">  30 </td> <td> bile acid and bile salt transport </td> <td> AKR1C1, ABCC3, NR1H4 </td> </tr>
  <tr> <td> 71 </td> <td align="center"> GO:0034694 </td> <td align="right"> 0.04 </td> <td align="right"> 4.11 </td> <td align="right"> 0.79 </td> <td align="right">   3 </td> <td align="right">  30 </td> <td> response to prostaglandin </td> <td> AKR1C2, AKT1, GNB1 </td> </tr>
  <tr> <td> 72 </td> <td align="center"> GO:0050435 </td> <td align="right"> 0.04 </td> <td align="right"> 4.11 </td> <td align="right"> 0.79 </td> <td align="right">   3 </td> <td align="right">  30 </td> <td> amyloid-beta metabolic process </td> <td> GSK3A, APEH, PRNP </td> </tr>
  <tr> <td> 73 </td> <td align="center"> GO:0044243 </td> <td align="right"> 0.00 </td> <td align="right"> 4.01 </td> <td align="right"> 1.91 </td> <td align="right">   7 </td> <td align="right">  72 </td> <td> multicellular organismal catabolic process </td> <td> COL4A3, COL12A1, COL13A1, COL19A1, ADAMTS14, CST3, COL25A1 </td> </tr>
  <tr> <td> 74 </td> <td align="center"> GO:0090279 </td> <td align="right"> 0.05 </td> <td align="right"> 3.96 </td> <td align="right"> 0.82 </td> <td align="right">   3 </td> <td align="right">  31 </td> <td> regulation of calcium ion import </td> <td> PRNP, CASK, HOMER1 </td> </tr>
  <tr> <td> 75 </td> <td align="center"> GO:0061180 </td> <td align="right"> 0.01 </td> <td align="right"> 3.91 </td> <td align="right"> 1.67 </td> <td align="right">   6 </td> <td align="right">  63 </td> <td> mammary gland epithelium development </td> <td> CEBPB, ERBB4, AKT1, CCND1, WNT7B, NTN1 </td> </tr>
  <tr> <td> 76 </td> <td align="center"> GO:0010761 </td> <td align="right"> 0.02 </td> <td align="right"> 3.90 </td> <td align="right"> 1.11 </td> <td align="right">   4 </td> <td align="right">  42 </td> <td> fibroblast migration </td> <td> TMEM201, AKT1, FGF2, SYNE2 </td> </tr>
  <tr> <td> 77 </td> <td align="center"> GO:0072527 </td> <td align="right"> 0.00 </td> <td align="right"> 3.83 </td> <td align="right"> 1.98 </td> <td align="right">   7 </td> <td align="right">  75 </td> <td> pyrimidine-containing compound metabolic process </td> <td> SLC19A2, DCTD, APOBEC3A, ERH, NT5E, UNG, MBD4 </td> </tr>
  <tr> <td> 78 </td> <td align="center"> GO:0032007 </td> <td align="right"> 0.03 </td> <td align="right"> 3.80 </td> <td align="right"> 1.14 </td> <td align="right">   4 </td> <td align="right">  43 </td> <td> negative regulation of TOR signaling </td> <td> FLCN, GSK3A, AKT1S1, DEPDC5 </td> </tr>
  <tr> <td> 79 </td> <td align="center"> GO:0071260 </td> <td align="right"> 0.00 </td> <td align="right"> 3.72 </td> <td align="right"> 2.04 </td> <td align="right">   7 </td> <td align="right">  77 </td> <td> cellular response to mechanical stimulus </td> <td> AKT1, IRF1, MAP3K1, TLR7, BAK1, CASP1, CRADD </td> </tr>
  <tr> <td> 80 </td> <td align="center"> GO:0001836 </td> <td align="right"> 0.01 </td> <td align="right"> 3.71 </td> <td align="right"> 1.46 </td> <td align="right">   5 </td> <td align="right">  55 </td> <td> release of cytochrome c from mitochondria </td> <td> AKT1, LMNA, MFF, BAK1, PINK1 </td> </tr>
  <tr> <td> 81 </td> <td align="center"> GO:0010517 </td> <td align="right"> 0.01 </td> <td align="right"> 3.71 </td> <td align="right"> 1.46 </td> <td align="right">   5 </td> <td align="right">  55 </td> <td> regulation of phospholipase activity </td> <td> FGF2, FGFR3, HTR2B, ITK, PDGFRA </td> </tr>
  <tr> <td> 82 </td> <td align="center"> GO:0097306 </td> <td align="right"> 0.01 </td> <td align="right"> 3.71 </td> <td align="right"> 1.46 </td> <td align="right">   5 </td> <td align="right">  55 </td> <td> cellular response to alcohol </td> <td> CTNNA1, AKT1, GNB1, KLF4, CDH1 </td> </tr>
  <tr> <td> 83 </td> <td align="center"> GO:0031018 </td> <td align="right"> 0.03 </td> <td align="right"> 3.70 </td> <td align="right"> 1.16 </td> <td align="right">   4 </td> <td align="right">  44 </td> <td> endocrine pancreas development </td> <td> AKT1, RFX6, GSK3A, BAK1 </td> </tr>
  <tr> <td> 84 </td> <td align="center"> GO:0006220 </td> <td align="right"> 0.03 </td> <td align="right"> 3.61 </td> <td align="right"> 1.19 </td> <td align="right">   4 </td> <td align="right">  45 </td> <td> pyrimidine nucleotide metabolic process </td> <td> DCTD, ERH, UNG, MBD4 </td> </tr>
  <tr> <td> 85 </td> <td align="center"> GO:0006754 </td> <td align="right"> 0.03 </td> <td align="right"> 3.61 </td> <td align="right"> 1.19 </td> <td align="right">   4 </td> <td align="right">  45 </td> <td> ATP biosynthetic process </td> <td> FLCN, LDHC, PINK1, VPS9D1 </td> </tr>
  <tr> <td> 86 </td> <td align="center"> GO:0018196 </td> <td align="right"> 0.03 </td> <td align="right"> 3.61 </td> <td align="right"> 1.19 </td> <td align="right">   4 </td> <td align="right">  45 </td> <td> peptidyl-asparagine modification </td> <td> DDOST, ASGR2, HIF1AN, ST6GAL2 </td> </tr>
  <tr> <td> 87 </td> <td align="center"> GO:1903078 </td> <td align="right"> 0.03 </td> <td align="right"> 3.61 </td> <td align="right"> 1.19 </td> <td align="right">   4 </td> <td align="right">  45 </td> <td> positive regulation of protein localization to plasma membrane </td> <td> AKT1, KCNJ11, PRNP, SPTBN1 </td> </tr>
  <tr> <td> 88 </td> <td align="center"> GO:0000079 </td> <td align="right"> 0.01 </td> <td align="right"> 3.57 </td> <td align="right"> 2.12 </td> <td align="right">   7 </td> <td align="right">  80 </td> <td> regulation of cyclin-dependent protein serine/threonine kinase activity </td> <td> AKT1, CCNY, CCND1, CDK5RAP3, CCNB3, CCNG1, CDC25A </td> </tr>
  <tr> <td> 89 </td> <td align="center"> GO:0060191 </td> <td align="right"> 0.01 </td> <td align="right"> 3.57 </td> <td align="right"> 2.12 </td> <td align="right">   7 </td> <td align="right">  80 </td> <td> regulation of lipase activity </td> <td> FGF2, FGFR3, HTR2B, ITK, PDGFRA, ANGPTL8, LMF1 </td> </tr>
  <tr> <td> 90 </td> <td align="center"> GO:0046622 </td> <td align="right"> 0.02 </td> <td align="right"> 3.57 </td> <td align="right"> 1.51 </td> <td align="right">   5 </td> <td align="right">  57 </td> <td> positive regulation of organ growth </td> <td> BASP1, ERBB4, AKT1, FGF2, YBX3 </td> </tr>
  <tr> <td> 91 </td> <td align="center"> GO:0046834 </td> <td align="right"> 0.00 </td> <td align="right"> 3.47 </td> <td align="right"> 2.81 </td> <td align="right">   9 </td> <td align="right"> 106 </td> <td> lipid phosphorylation </td> <td> ERBB4, FGF2, FGFR3, EFR3B, EFR3A, PDGFRA, SPHK2, DGKD, FGF16 </td> </tr>
  <tr> <td> 92 </td> <td align="center"> GO:2000117 </td> <td align="right"> 0.00 </td> <td align="right"> 3.47 </td> <td align="right"> 2.81 </td> <td align="right">   9 </td> <td align="right"> 106 </td> <td> negative regulation of cysteine-type endopeptidase activity </td> <td> CST3, CST5, AKT1, TNFAIP8, IFI16, BIRC7, BCL2L12, CST7, KLF4 </td> </tr>
  <tr> <td> 93 </td> <td align="center"> GO:0010823 </td> <td align="right"> 0.04 </td> <td align="right"> 3.45 </td> <td align="right"> 1.24 </td> <td align="right">   4 </td> <td align="right">  47 </td> <td> negative regulation of mitochondrion organization </td> <td> FLCN, AKT1, LMNA, PINK1 </td> </tr>
  <tr> <td> 94 </td> <td align="center"> GO:1904029 </td> <td align="right"> 0.01 </td> <td align="right"> 3.43 </td> <td align="right"> 2.20 </td> <td align="right">   7 </td> <td align="right">  83 </td> <td> regulation of cyclin-dependent protein kinase activity </td> <td> AKT1, CCNY, CCND1, CDK5RAP3, CCNB3, CCNG1, CDC25A </td> </tr>
  <tr> <td> 95 </td> <td align="center"> GO:0043044 </td> <td align="right"> 0.01 </td> <td align="right"> 3.38 </td> <td align="right"> 1.91 </td> <td align="right">   6 </td> <td align="right">  72 </td> <td> ATP-dependent chromatin remodeling </td> <td> CENPA, CENPC, ITGB3BP, CENPI, VPS72, CENPL </td> </tr>
  <tr> <td> 96 </td> <td align="center"> GO:0030834 </td> <td align="right"> 0.04 </td> <td align="right"> 3.37 </td> <td align="right"> 1.27 </td> <td align="right">   4 </td> <td align="right">  48 </td> <td> regulation of actin filament depolymerization </td> <td> EPS8, SPTBN5, SPTBN1, SCIN </td> </tr>
  <tr> <td> 97 </td> <td align="center"> GO:0043525 </td> <td align="right"> 0.04 </td> <td align="right"> 3.37 </td> <td align="right"> 1.27 </td> <td align="right">   4 </td> <td align="right">  48 </td> <td> positive regulation of neuron apoptotic process </td> <td> GRIK2, GSK3A, PRNP, CDC34 </td> </tr>
  <tr> <td> 98 </td> <td align="center"> GO:0007062 </td> <td align="right"> 0.00 </td> <td align="right"> 3.22 </td> <td align="right"> 3.33 </td> <td align="right">  10 </td> <td align="right"> 126 </td> <td> sister chromatid cohesion </td> <td> CENPA, CENPC, CDCA5, ITGB3BP, CENPI, NSL1, NSMCE2, CDCA8, CENPL, BUB3 </td> </tr>
  <tr> <td> 99 </td> <td align="center"> GO:0030837 </td> <td align="right"> 0.04 </td> <td align="right"> 3.22 </td> <td align="right"> 1.32 </td> <td align="right">   4 </td> <td align="right">  50 </td> <td> negative regulation of actin filament polymerization </td> <td> EPS8, SPTBN5, SPTBN1, SCIN </td> </tr>
  <tr> <td> 100 </td> <td align="center"> GO:0046324 </td> <td align="right"> 0.03 </td> <td align="right"> 3.20 </td> <td align="right"> 1.67 </td> <td align="right">   5 </td> <td align="right">  63 </td> <td> regulation of glucose import </td> <td> AKT1, GSK3A, RTN2, PEA15, NR1H4 </td> </tr>
  <tr> <td> 101 </td> <td align="center"> GO:0006919 </td> <td align="right"> 0.02 </td> <td align="right"> 3.18 </td> <td align="right"> 2.01 </td> <td align="right">   6 </td> <td align="right">  76 </td> <td> activation of cysteine-type endopeptidase activity involved in apoptotic process </td> <td> COL4A3, F2R, HSPE1, BAK1, CASP1, CRADD </td> </tr>
  <tr> <td> 102 </td> <td align="center"> GO:0030042 </td> <td align="right"> 0.05 </td> <td align="right"> 3.15 </td> <td align="right"> 1.35 </td> <td align="right">   4 </td> <td align="right">  51 </td> <td> actin filament depolymerization </td> <td> EPS8, SPTBN5, SPTBN1, SCIN </td> </tr>
  <tr> <td> 103 </td> <td align="center"> GO:0032663 </td> <td align="right"> 0.05 </td> <td align="right"> 3.15 </td> <td align="right"> 1.35 </td> <td align="right">   4 </td> <td align="right">  51 </td> <td> regulation of interleukin-2 production </td> <td> PRNP, SPTBN1, MAP3K7, NR1H4 </td> </tr>
  <tr> <td> 104 </td> <td align="center"> GO:1904377 </td> <td align="right"> 0.05 </td> <td align="right"> 3.15 </td> <td align="right"> 1.35 </td> <td align="right">   4 </td> <td align="right">  51 </td> <td> positive regulation of protein localization to cell periphery </td> <td> AKT1, KCNJ11, PRNP, SPTBN1 </td> </tr>
  <tr> <td> 105 </td> <td align="center"> GO:0007269 </td> <td align="right"> 0.00 </td> <td align="right"> 3.14 </td> <td align="right"> 3.41 </td> <td align="right">  10 </td> <td align="right"> 129 </td> <td> neurotransmitter secretion </td> <td> SYT9, RIMS1, HCRT, SYT17, SLC18A2, SLC18A3, SLC22A2, SYN2, SYN3, CASK </td> </tr>
  <tr> <td> 106 </td> <td align="center"> GO:0099643 </td> <td align="right"> 0.00 </td> <td align="right"> 3.14 </td> <td align="right"> 3.41 </td> <td align="right">  10 </td> <td align="right"> 129 </td> <td> signal release from synapse </td> <td> SYT9, RIMS1, HCRT, SYT17, SLC18A2, SLC18A3, SLC22A2, SYN2, SYN3, CASK </td> </tr>
  <tr> <td> 107 </td> <td align="center"> GO:0032652 </td> <td align="right"> 0.03 </td> <td align="right"> 3.09 </td> <td align="right"> 1.72 </td> <td align="right">   5 </td> <td align="right">  65 </td> <td> regulation of interleukin-1 production </td> <td> F2R, IFI16, CARD17, CASP1, NR1H4 </td> </tr>
  <tr> <td> 108 </td> <td align="center"> GO:0019748 </td> <td align="right"> 0.05 </td> <td align="right"> 3.09 </td> <td align="right"> 1.38 </td> <td align="right">   4 </td> <td align="right">  52 </td> <td> secondary metabolic process </td> <td> CYP2A6, AKR1C1, AKR1C2, UGT1A8 </td> </tr>
  <tr> <td> 109 </td> <td align="center"> GO:0070268 </td> <td align="right"> 0.01 </td> <td align="right"> 3.07 </td> <td align="right"> 2.78 </td> <td align="right">   8 </td> <td align="right"> 105 </td> <td> cornification </td> <td> KRT78, KRT6C, KRT33A, KRT81, KRT85, KRT86, KRT37, KRT36 </td> </tr>
  <tr> <td> 110 </td> <td align="center"> GO:0002028 </td> <td align="right"> 0.02 </td> <td align="right"> 3.01 </td> <td align="right"> 2.12 </td> <td align="right">   6 </td> <td align="right">  80 </td> <td> regulation of sodium ion transport </td> <td> DMD, DMPK, AKT1, GLRX, FXYD1, SCN5A </td> </tr>
  <tr> <td> 111 </td> <td align="center"> GO:0046854 </td> <td align="right"> 0.01 </td> <td align="right"> 2.96 </td> <td align="right"> 2.51 </td> <td align="right">   7 </td> <td align="right">  95 </td> <td> phosphatidylinositol phosphorylation </td> <td> ERBB4, FGF2, FGFR3, EFR3B, EFR3A, PDGFRA, FGF16 </td> </tr>
  <tr> <td> 112 </td> <td align="center"> GO:0099531 </td> <td align="right"> 0.00 </td> <td align="right"> 2.92 </td> <td align="right"> 3.65 </td> <td align="right">  10 </td> <td align="right"> 138 </td> <td> presynaptic process involved in chemical synaptic transmission </td> <td> SYT9, RIMS1, HCRT, SYT17, SLC18A2, SLC18A3, SLC22A2, SYN2, SYN3, CASK </td> </tr>
  <tr> <td> 113 </td> <td align="center"> GO:2000116 </td> <td align="right"> 0.00 </td> <td align="right"> 2.92 </td> <td align="right"> 5.90 </td> <td align="right">  16 </td> <td align="right"> 223 </td> <td> regulation of cysteine-type endopeptidase activity </td> <td> BCAP31, COL4A3, CST3, CST5, AKT1, F2R, TNFAIP8, HSPE1, IFI16, BAK1, BIRC7, CASP1, BCL2L12, CST7, CRADD, KLF4 </td> </tr>
  <tr> <td> 114 </td> <td align="center"> GO:0031571 </td> <td align="right"> 0.04 </td> <td align="right"> 2.90 </td> <td align="right"> 1.83 </td> <td align="right">   5 </td> <td align="right">  69 </td> <td> mitotic G1 DNA damage checkpoint </td> <td> CENPJ, RBL2, CCND1, E2F8, CRADD </td> </tr>
  <tr> <td> 115 </td> <td align="center"> GO:0044819 </td> <td align="right"> 0.04 </td> <td align="right"> 2.90 </td> <td align="right"> 1.83 </td> <td align="right">   5 </td> <td align="right">  69 </td> <td> mitotic G1/S transition checkpoint </td> <td> CENPJ, RBL2, CCND1, E2F8, CRADD </td> </tr>
  <tr> <td> 116 </td> <td align="center"> GO:0070613 </td> <td align="right"> 0.01 </td> <td align="right"> 2.89 </td> <td align="right"> 2.57 </td> <td align="right">   7 </td> <td align="right">  97 </td> <td> regulation of protein processing </td> <td> CR1, INPP5B, ANGPTL8, PRNP, CHAC1, BIRC7, BCL2L12 </td> </tr>
  <tr> <td> 117 </td> <td align="center"> GO:0099565 </td> <td align="right"> 0.01 </td> <td align="right"> 2.87 </td> <td align="right"> 2.96 </td> <td align="right">   8 </td> <td align="right"> 112 </td> <td> chemical synaptic transmission, postsynaptic </td> <td> DMPK, AKT1, RIMS1, GRIK2, GSK3A, HCRT, CHRNA9, CBLN1 </td> </tr>
  <tr> <td> 118 </td> <td align="center"> GO:0035019 </td> <td align="right"> 0.04 </td> <td align="right"> 2.85 </td> <td align="right"> 1.85 </td> <td align="right">   5 </td> <td align="right">  70 </td> <td> somatic stem cell population maintenance </td> <td> CDX2, EPAS1, FGF2, VPS72, KLF4 </td> </tr>
  <tr> <td> 119 </td> <td align="center"> GO:0044783 </td> <td align="right"> 0.04 </td> <td align="right"> 2.85 </td> <td align="right"> 1.85 </td> <td align="right">   5 </td> <td align="right">  70 </td> <td> G1 DNA damage checkpoint </td> <td> CENPJ, RBL2, CCND1, E2F8, CRADD </td> </tr>
  <tr> <td> 120 </td> <td align="center"> GO:0019933 </td> <td align="right"> 0.02 </td> <td align="right"> 2.83 </td> <td align="right"> 2.62 </td> <td align="right">   7 </td> <td align="right">  99 </td> <td> cAMP-mediated signaling </td> <td> GPR78, GNB1, HTR5A, TSHR, UBE2B, ADM2, CDC34 </td> </tr>
  <tr> <td> 121 </td> <td align="center"> GO:1903317 </td> <td align="right"> 0.02 </td> <td align="right"> 2.83 </td> <td align="right"> 2.62 </td> <td align="right">   7 </td> <td align="right">  99 </td> <td> regulation of protein maturation </td> <td> CR1, INPP5B, ANGPTL8, PRNP, CHAC1, BIRC7, BCL2L12 </td> </tr>
  <tr> <td> 122 </td> <td align="center"> GO:0032963 </td> <td align="right"> 0.01 </td> <td align="right"> 2.78 </td> <td align="right"> 3.04 </td> <td align="right">   8 </td> <td align="right"> 115 </td> <td> collagen metabolic process </td> <td> COL4A3, COL12A1, COL13A1, COL19A1, ADAMTS14, CST3, F2R, COL25A1 </td> </tr>
  <tr> <td> 123 </td> <td align="center"> GO:0010827 </td> <td align="right"> 0.04 </td> <td align="right"> 2.77 </td> <td align="right"> 1.91 </td> <td align="right">   5 </td> <td align="right">  72 </td> <td> regulation of glucose transport </td> <td> AKT1, GSK3A, RTN2, PEA15, NR1H4 </td> </tr>
  <tr> <td> 124 </td> <td align="center"> GO:0060359 </td> <td align="right"> 0.01 </td> <td align="right"> 2.76 </td> <td align="right"> 3.07 </td> <td align="right">   8 </td> <td align="right"> 116 </td> <td> response to ammonium ion </td> <td> HDAC5, GABRB1, AOC1, GNB1, HNRNPD, PEA15, HOMER2, HOMER1 </td> </tr>
  <tr> <td> 125 </td> <td align="center"> GO:1903312 </td> <td align="right"> 0.04 </td> <td align="right"> 2.73 </td> <td align="right"> 1.93 </td> <td align="right">   5 </td> <td align="right">  73 </td> <td> negative regulation of mRNA metabolic process </td> <td> SAP18, CIRBP, RBMX, HNRNPD, YBX3 </td> </tr>
  <tr> <td> 126 </td> <td align="center"> GO:0006986 </td> <td align="right"> 0.00 </td> <td align="right"> 2.73 </td> <td align="right"> 4.29 </td> <td align="right">  11 </td> <td align="right"> 162 </td> <td> response to unfolded protein </td> <td> DCTN1, HSPB7, GSK3A, HSPE1, LMNA, YOD1, BAK1, CCND1, CHAC1, CDK5RAP3, HSPB3 </td> </tr>
  <tr> <td> 127 </td> <td align="center"> GO:0001892 </td> <td align="right"> 0.03 </td> <td align="right"> 2.72 </td> <td align="right"> 2.33 </td> <td align="right">   6 </td> <td align="right">  88 </td> <td> embryonic placenta development </td> <td> CDX2, CEBPB, EPAS1, AKT1, WNT7B, E2F8 </td> </tr>
  <tr> <td> 128 </td> <td align="center"> GO:0043535 </td> <td align="right"> 0.05 </td> <td align="right"> 2.69 </td> <td align="right"> 1.96 </td> <td align="right">   5 </td> <td align="right">  74 </td> <td> regulation of blood vessel endothelial cell migration </td> <td> HDAC5, AKT1, FGF2, GDF2, KLF4 </td> </tr>
  <tr> <td> 129 </td> <td align="center"> GO:0044259 </td> <td align="right"> 0.01 </td> <td align="right"> 2.68 </td> <td align="right"> 3.15 </td> <td align="right">   8 </td> <td align="right"> 119 </td> <td> multicellular organismal macromolecule metabolic process </td> <td> COL4A3, COL12A1, COL13A1, COL19A1, ADAMTS14, CST3, F2R, COL25A1 </td> </tr>
  <tr> <td> 130 </td> <td align="center"> GO:0031929 </td> <td align="right"> 0.02 </td> <td align="right"> 2.68 </td> <td align="right"> 2.75 </td> <td align="right">   7 </td> <td align="right"> 104 </td> <td> TOR signaling </td> <td> FLCN, AKT1, GSK3A, HTR6, PINK1, AKT1S1, DEPDC5 </td> </tr>
  <tr> <td> 131 </td> <td align="center"> GO:0008637 </td> <td align="right"> 0.01 </td> <td align="right"> 2.66 </td> <td align="right"> 3.18 </td> <td align="right">   8 </td> <td align="right"> 120 </td> <td> apoptotic mitochondrial changes </td> <td> ERBB4, AKT1, GSK3A, LMNA, MFF, BAK1, PINK1, ZNF205 </td> </tr>
  <tr> <td> 132 </td> <td align="center"> GO:0045834 </td> <td align="right"> 0.01 </td> <td align="right"> 2.66 </td> <td align="right"> 3.18 </td> <td align="right">   8 </td> <td align="right"> 120 </td> <td> positive regulation of lipid metabolic process </td> <td> EPHA8, AKT1, FGF2, FGFR3, HTR2B, PDGFRA, NSMAF, NR1H4 </td> </tr>
  <tr> <td> 133 </td> <td align="center"> GO:0032612 </td> <td align="right"> 0.05 </td> <td align="right"> 2.65 </td> <td align="right"> 1.98 </td> <td align="right">   5 </td> <td align="right">  75 </td> <td> interleukin-1 production </td> <td> F2R, IFI16, CARD17, CASP1, NR1H4 </td> </tr>
  <tr> <td> 134 </td> <td align="center"> GO:0046323 </td> <td align="right"> 0.05 </td> <td align="right"> 2.65 </td> <td align="right"> 1.98 </td> <td align="right">   5 </td> <td align="right">  75 </td> <td> glucose import </td> <td> AKT1, GSK3A, RTN2, PEA15, NR1H4 </td> </tr>
  <tr> <td> 135 </td> <td align="center"> GO:2001056 </td> <td align="right"> 0.02 </td> <td align="right"> 2.61 </td> <td align="right"> 3.23 </td> <td align="right">   8 </td> <td align="right"> 122 </td> <td> positive regulation of cysteine-type endopeptidase activity </td> <td> BCAP31, COL4A3, F2R, HSPE1, IFI16, BAK1, CASP1, CRADD </td> </tr>
  <tr> <td> 136 </td> <td align="center"> GO:0034728 </td> <td align="right"> 0.01 </td> <td align="right"> 2.57 </td> <td align="right"> 4.10 </td> <td align="right">  10 </td> <td align="right"> 155 </td> <td> nucleosome organization </td> <td> CENPA, CENPC, ITGB3BP, CENPI, SET, VPS72, TSPY4, IPO4, CENPL, HIST3H2A </td> </tr>
  <tr> <td> 137 </td> <td align="center"> GO:0019935 </td> <td align="right"> 0.03 </td> <td align="right"> 2.53 </td> <td align="right"> 2.91 </td> <td align="right">   7 </td> <td align="right"> 110 </td> <td> cyclic-nucleotide-mediated signaling </td> <td> GPR78, GNB1, HTR5A, TSHR, UBE2B, ADM2, CDC34 </td> </tr>
  <tr> <td> 138 </td> <td align="center"> GO:0032609 </td> <td align="right"> 0.04 </td> <td align="right"> 2.50 </td> <td align="right"> 2.51 </td> <td align="right">   6 </td> <td align="right">  95 </td> <td> interferon-gamma production </td> <td> IRF8, ITK, TLR7, PRNP, ISG15, NR1H4 </td> </tr>
  <tr> <td> 139 </td> <td align="center"> GO:0034754 </td> <td align="right"> 0.03 </td> <td align="right"> 2.50 </td> <td align="right"> 2.94 </td> <td align="right">   7 </td> <td align="right"> 111 </td> <td> cellular hormone metabolic process </td> <td> AKR1C1, AKR1C2, HSD17B3, CYP26C1, PDGFRA, UGT1A8, UGT1A9 </td> </tr>
  <tr> <td> 140 </td> <td align="center"> GO:0006888 </td> <td align="right"> 0.01 </td> <td align="right"> 2.49 </td> <td align="right"> 4.66 </td> <td align="right">  11 </td> <td align="right"> 176 </td> <td> ER to Golgi vesicle-mediated transport </td> <td> BCAP31, COPA, DCTN1, F5, SPTBN5, PPP6C, LMF1, SPTBN1, COG3, GBF1, SEC24C </td> </tr>
  <tr> <td> 141 </td> <td align="center"> GO:0006334 </td> <td align="right"> 0.02 </td> <td align="right"> 2.48 </td> <td align="right"> 3.39 </td> <td align="right">   8 </td> <td align="right"> 128 </td> <td> nucleosome assembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, SET, TSPY4, IPO4, CENPL </td> </tr>
  <tr> <td> 142 </td> <td align="center"> GO:0009411 </td> <td align="right"> 0.02 </td> <td align="right"> 2.48 </td> <td align="right"> 3.39 </td> <td align="right">   8 </td> <td align="right"> 128 </td> <td> response to UV </td> <td> CIRBP, AKT1, BAK1, CCND1, UBE2B, WRN, HIST3H2A, CDC25A </td> </tr>
  <tr> <td> 143 </td> <td align="center"> GO:0043280 </td> <td align="right"> 0.03 </td> <td align="right"> 2.48 </td> <td align="right"> 2.96 </td> <td align="right">   7 </td> <td align="right"> 112 </td> <td> positive regulation of cysteine-type endopeptidase activity involved in apoptotic process </td> <td> BCAP31, COL4A3, F2R, HSPE1, BAK1, CASP1, CRADD </td> </tr>
  <tr> <td> 144 </td> <td align="center"> GO:0043123 </td> <td align="right"> 0.01 </td> <td align="right"> 2.45 </td> <td align="right"> 4.74 </td> <td align="right">  11 </td> <td align="right"> 179 </td> <td> positive regulation of I-kappaB kinase/NF-kappaB signaling </td> <td> TRIM13, AKT1, F2R, HTR2B, IRAK4, SHISA5, TLR7, PINK1, MAP3K7, TRAF5, CASP1 </td> </tr>
  <tr> <td> 145 </td> <td align="center"> GO:0043281 </td> <td align="right"> 0.01 </td> <td align="right"> 2.44 </td> <td align="right"> 5.19 </td> <td align="right">  12 </td> <td align="right"> 196 </td> <td> regulation of cysteine-type endopeptidase activity involved in apoptotic process </td> <td> BCAP31, COL4A3, AKT1, F2R, TNFAIP8, HSPE1, BAK1, BIRC7, CASP1, BCL2L12, CRADD, KLF4 </td> </tr>
  <tr> <td> 146 </td> <td align="center"> GO:0035966 </td> <td align="right"> 0.01 </td> <td align="right"> 2.43 </td> <td align="right"> 4.76 </td> <td align="right">  11 </td> <td align="right"> 180 </td> <td> response to topologically incorrect protein </td> <td> DCTN1, HSPB7, GSK3A, HSPE1, LMNA, YOD1, BAK1, CCND1, CHAC1, CDK5RAP3, HSPB3 </td> </tr>
  <tr> <td> 147 </td> <td align="center"> GO:0006493 </td> <td align="right"> 0.05 </td> <td align="right"> 2.42 </td> <td align="right"> 2.59 </td> <td align="right">   6 </td> <td align="right">  98 </td> <td> protein O-linked glycosylation </td> <td> GALNT6, B3GNT6, GALNT2, GALNT9, TRAK2, B3GNT5 </td> </tr>
  <tr> <td> 148 </td> <td align="center"> GO:0007156 </td> <td align="right"> 0.02 </td> <td align="right"> 2.41 </td> <td align="right"> 3.92 </td> <td align="right">   9 </td> <td align="right"> 148 </td> <td> homophilic cell adhesion via plasma membrane adhesion molecules </td> <td> CDH2, CDH6, GYPC, PCDHGA11, PCDHB11, DSCAML1, CELSR1, CLSTN3, CDH1 </td> </tr>
  <tr> <td> 149 </td> <td align="center"> GO:0010950 </td> <td align="right"> 0.02 </td> <td align="right"> 2.41 </td> <td align="right"> 3.92 </td> <td align="right">   9 </td> <td align="right"> 148 </td> <td> positive regulation of endopeptidase activity </td> <td> BCAP31, COL4A3, CR1, F2R, HSPE1, IFI16, BAK1, CASP1, CRADD </td> </tr>
  <tr> <td> 150 </td> <td align="center"> GO:0010952 </td> <td align="right"> 0.01 </td> <td align="right"> 2.41 </td> <td align="right"> 4.37 </td> <td align="right">  10 </td> <td align="right"> 165 </td> <td> positive regulation of peptidase activity </td> <td> BCAP31, COL4A3, CR1, F2R, HSPE1, IFI16, BAK1, PINK1, CASP1, CRADD </td> </tr>
  <tr> <td> 151 </td> <td align="center"> GO:0044773 </td> <td align="right"> 0.05 </td> <td align="right"> 2.39 </td> <td align="right"> 2.62 </td> <td align="right">   6 </td> <td align="right">  99 </td> <td> mitotic DNA damage checkpoint </td> <td> CENPJ, RBL2, CCND1, E2F8, CDK5RAP3, CRADD </td> </tr>
  <tr> <td> 152 </td> <td align="center"> GO:0046620 </td> <td align="right"> 0.05 </td> <td align="right"> 2.37 </td> <td align="right"> 2.65 </td> <td align="right">   6 </td> <td align="right"> 100 </td> <td> regulation of organ growth </td> <td> BASP1, ERBB4, AKT1, FGF2, GSK3A, YBX3 </td> </tr>
  <tr> <td> 153 </td> <td align="center"> GO:0060079 </td> <td align="right"> 0.05 </td> <td align="right"> 2.37 </td> <td align="right"> 2.65 </td> <td align="right">   6 </td> <td align="right"> 100 </td> <td> excitatory postsynaptic potential </td> <td> DMPK, RIMS1, GRIK2, HCRT, CHRNA9, CBLN1 </td> </tr>
  <tr> <td> 154 </td> <td align="center"> GO:0030258 </td> <td align="right"> 0.00 </td> <td align="right"> 2.35 </td> <td align="right"> 6.75 </td> <td align="right">  15 </td> <td align="right"> 255 </td> <td> lipid modification </td> <td> CRAT, ECHS1, ERBB4, AKT1, FGF2, FGFR3, EFR3B, EFR3A, GCDH, INPP5B, PDGFRA, SLC35C1, SPHK2, DGKD, FGF16 </td> </tr>
  <tr> <td> 155 </td> <td align="center"> GO:0071229 </td> <td align="right"> 0.01 </td> <td align="right"> 2.32 </td> <td align="right"> 4.98 </td> <td align="right">  11 </td> <td align="right"> 188 </td> <td> cellular response to acid chemical </td> <td> CEBPB, AKR1C1, AKR1C2, AKT1, GNB1, HNRNPD, PDGFRA, PINK1, WNT7B, KLF4, NR1H4 </td> </tr>
  <tr> <td> 156 </td> <td align="center"> GO:0001505 </td> <td align="right"> 0.02 </td> <td align="right"> 2.32 </td> <td align="right"> 4.53 </td> <td align="right">  10 </td> <td align="right"> 171 </td> <td> regulation of neurotransmitter levels </td> <td> SYT9, RIMS1, HCRT, SYT17, SLC18A2, SLC18A3, SLC22A2, SYN2, SYN3, CASK </td> </tr>
  <tr> <td> 157 </td> <td align="center"> GO:0007163 </td> <td align="right"> 0.02 </td> <td align="right"> 2.30 </td> <td align="right"> 4.55 </td> <td align="right">  10 </td> <td align="right"> 172 </td> <td> establishment or maintenance of cell polarity </td> <td> CDX2, CENPA, CTNNA1, DCTN1, SYNE2, LMNA, PARD6A, WNT7B, SNX27, GBF1 </td> </tr>
  <tr> <td> 158 </td> <td align="center"> GO:0030968 </td> <td align="right"> 0.04 </td> <td align="right"> 2.30 </td> <td align="right"> 3.18 </td> <td align="right">   7 </td> <td align="right"> 120 </td> <td> endoplasmic reticulum unfolded protein response </td> <td> DCTN1, GSK3A, LMNA, YOD1, BAK1, CCND1, CDK5RAP3 </td> </tr>
  <tr> <td> 159 </td> <td align="center"> GO:0098742 </td> <td align="right"> 0.01 </td> <td align="right"> 2.30 </td> <td align="right"> 5.95 </td> <td align="right">  13 </td> <td align="right"> 225 </td> <td> cell-cell adhesion via plasma-membrane adhesion molecules </td> <td> CDH2, CDH6, CLDN14, GYPC, PCDHGA11, PCDHB11, DSCAML1, CBLN1, CLDN9, KLF4, CELSR1, CLSTN3, CDH1 </td> </tr>
  <tr> <td> 160 </td> <td align="center"> GO:0046661 </td> <td align="right"> 0.02 </td> <td align="right"> 2.26 </td> <td align="right"> 4.15 </td> <td align="right">   9 </td> <td align="right"> 157 </td> <td> male sex differentiation </td> <td> ZFP42, CST3, CTNNA1, HOXD13, HSD17B3, LRP2, PDGFRA, CCND1, YBX3 </td> </tr>
  <tr> <td> 161 </td> <td align="center"> GO:0043270 </td> <td align="right"> 0.01 </td> <td align="right"> 2.26 </td> <td align="right"> 6.03 </td> <td align="right">  13 </td> <td align="right"> 228 </td> <td> positive regulation of ion transport </td> <td> DMD, AKT1, F2R, GLRX, HCRT, KCNJ11, FXYD1, BAK1, SCN5A, PINK1, ORAI1, CASK, HOMER1 </td> </tr>
  <tr> <td> 162 </td> <td align="center"> GO:0044236 </td> <td align="right"> 0.03 </td> <td align="right"> 2.25 </td> <td align="right"> 3.70 </td> <td align="right">   8 </td> <td align="right"> 140 </td> <td> multicellular organism metabolic process </td> <td> COL4A3, COL12A1, COL13A1, COL19A1, ADAMTS14, CST3, F2R, COL25A1 </td> </tr>
  <tr> <td> 163 </td> <td align="center"> GO:1901657 </td> <td align="right"> 0.03 </td> <td align="right"> 2.25 </td> <td align="right"> 3.70 </td> <td align="right">   8 </td> <td align="right"> 140 </td> <td> glycosyl compound metabolic process </td> <td> AKR1C1, AKR1C2, APOBEC3A, ERH, GUK1, LCT, NT5E, CASK </td> </tr>
  <tr> <td> 164 </td> <td align="center"> GO:0010951 </td> <td align="right"> 0.01 </td> <td align="right"> 2.25 </td> <td align="right"> 6.06 </td> <td align="right">  13 </td> <td align="right"> 229 </td> <td> negative regulation of endopeptidase activity </td> <td> COL4A3, CR1, CST3, CST5, CSTB, AKT1, TNFAIP8, IFI16, CARD17, BIRC7, BCL2L12, CST7, KLF4 </td> </tr>
  <tr> <td> 165 </td> <td align="center"> GO:0006836 </td> <td align="right"> 0.02 </td> <td align="right"> 2.25 </td> <td align="right"> 4.66 </td> <td align="right">  10 </td> <td align="right"> 176 </td> <td> neurotransmitter transport </td> <td> SYT9, RIMS1, HCRT, SYT17, SLC18A2, SLC18A3, SLC22A2, SYN2, SYN3, CASK </td> </tr>
  <tr> <td> 166 </td> <td align="center"> GO:0016485 </td> <td align="right"> 0.01 </td> <td align="right"> 2.19 </td> <td align="right"> 6.22 </td> <td align="right">  13 </td> <td align="right"> 235 </td> <td> protein processing </td> <td> CPA3, CR1, ASPRV1, SEC11A, IFI16, INPP5B, ANGPTL8, PRNP, BAK1, CHAC1, BIRC7, CASP1, BCL2L12 </td> </tr>
  <tr> <td> 167 </td> <td align="center"> GO:0001890 </td> <td align="right"> 0.04 </td> <td align="right"> 2.19 </td> <td align="right"> 3.81 </td> <td align="right">   8 </td> <td align="right"> 144 </td> <td> placenta development </td> <td> CDX2, CEBPB, EPAS1, EPOR, AKT1, HTRA1, WNT7B, E2F8 </td> </tr>
  <tr> <td> 168 </td> <td align="center"> GO:0043122 </td> <td align="right"> 0.01 </td> <td align="right"> 2.17 </td> <td align="right"> 6.27 </td> <td align="right">  13 </td> <td align="right"> 237 </td> <td> regulation of I-kappaB kinase/NF-kappaB signaling </td> <td> TRIM13, AKT1, F2R, HTR2B, IRAK4, SHISA5, TLR7, PINK1, MAP3K7, TLE1, TRAF5, CASP1, NR1H4 </td> </tr>
  <tr> <td> 169 </td> <td align="center"> GO:0007188 </td> <td align="right"> 0.04 </td> <td align="right"> 2.17 </td> <td align="right"> 3.84 </td> <td align="right">   8 </td> <td align="right"> 145 </td> <td> adenylate cyclase-modulating G-protein coupled receptor signaling pathway </td> <td> GPR78, GNAT2, GNB1, HTR5A, HTR7, GNAT3, TSHR, ADM2 </td> </tr>
  <tr> <td> 170 </td> <td align="center"> GO:0070085 </td> <td align="right"> 0.01 </td> <td align="right"> 2.16 </td> <td align="right"> 7.28 </td> <td align="right">  15 </td> <td align="right"> 275 </td> <td> glycosylation </td> <td> GALNT6, DDOST, B3GNT6, FUT6, GALNT2, ASGR2, GALNT9, SLC35C1, LMF1, TRAK2, COG3, B3GNT5, ST6GAL2, ALG2, B4GALT2 </td> </tr>
  <tr> <td> 171 </td> <td align="center"> GO:0048639 </td> <td align="right"> 0.03 </td> <td align="right"> 2.15 </td> <td align="right"> 4.37 </td> <td align="right">   9 </td> <td align="right"> 165 </td> <td> positive regulation of developmental growth </td> <td> BASP1, ERBB4, AKT1, FGF2, RIMS1, SYT17, ISLR2, YBX3, NTN1 </td> </tr>
  <tr> <td> 172 </td> <td align="center"> GO:0031497 </td> <td align="right"> 0.04 </td> <td align="right"> 2.14 </td> <td align="right"> 3.89 </td> <td align="right">   8 </td> <td align="right"> 147 </td> <td> chromatin assembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, SET, TSPY4, IPO4, CENPL </td> </tr>
  <tr> <td> 173 </td> <td align="center"> GO:0010466 </td> <td align="right"> 0.01 </td> <td align="right"> 2.13 </td> <td align="right"> 6.38 </td> <td align="right">  13 </td> <td align="right"> 241 </td> <td> negative regulation of peptidase activity </td> <td> COL4A3, CR1, CST3, CST5, CSTB, AKT1, TNFAIP8, IFI16, CARD17, BIRC7, BCL2L12, CST7, KLF4 </td> </tr>
  <tr> <td> 174 </td> <td align="center"> GO:0007548 </td> <td align="right"> 0.01 </td> <td align="right"> 2.12 </td> <td align="right"> 6.91 </td> <td align="right">  14 </td> <td align="right"> 261 </td> <td> sex differentiation </td> <td> BASP1, CEBPB, ZFP42, CST3, CTNNA1, CENPI, HOXD13, HSD17B3, LRP2, PDGFRA, BAK1, CCND1, TSPY4, YBX3 </td> </tr>
  <tr> <td> 175 </td> <td align="center"> GO:0019827 </td> <td align="right"> 0.04 </td> <td align="right"> 2.11 </td> <td align="right"> 3.94 </td> <td align="right">   8 </td> <td align="right"> 149 </td> <td> stem cell population maintenance </td> <td> CDH2, CDX2, EPAS1, ESRRB, FGF2, GNL3, VPS72, KLF4 </td> </tr>
  <tr> <td> 176 </td> <td align="center"> GO:0000077 </td> <td align="right"> 0.05 </td> <td align="right"> 2.09 </td> <td align="right"> 3.97 </td> <td align="right">   8 </td> <td align="right"> 150 </td> <td> DNA damage checkpoint </td> <td> CENPJ, RBL2, CCND1, E2F8, CEP63, CDK5RAP3, PEA15, CRADD </td> </tr>
  <tr> <td> 177 </td> <td align="center"> GO:0051054 </td> <td align="right"> 0.02 </td> <td align="right"> 2.09 </td> <td align="right"> 5.48 </td> <td align="right">  11 </td> <td align="right"> 207 </td> <td> positive regulation of DNA metabolic process </td> <td> CST3, AKT1, GNL3, HNRNPD, PDGFRA, UBE2B, UNG, WRN, E2F8, CDC7, KLF4 </td> </tr>
  <tr> <td> 178 </td> <td align="center"> GO:0006486 </td> <td align="right"> 0.01 </td> <td align="right"> 2.08 </td> <td align="right"> 7.04 </td> <td align="right">  14 </td> <td align="right"> 266 </td> <td> protein glycosylation </td> <td> GALNT6, DDOST, B3GNT6, FUT6, GALNT2, ASGR2, GALNT9, LMF1, TRAK2, COG3, B3GNT5, ST6GAL2, ALG2, B4GALT2 </td> </tr>
  <tr> <td> 179 </td> <td align="center"> GO:0043413 </td> <td align="right"> 0.01 </td> <td align="right"> 2.08 </td> <td align="right"> 7.04 </td> <td align="right">  14 </td> <td align="right"> 266 </td> <td> macromolecule glycosylation </td> <td> GALNT6, DDOST, B3GNT6, FUT6, GALNT2, ASGR2, GALNT9, LMF1, TRAK2, COG3, B3GNT5, ST6GAL2, ALG2, B4GALT2 </td> </tr>
  <tr> <td> 180 </td> <td align="center"> GO:0098727 </td> <td align="right"> 0.05 </td> <td align="right"> 2.08 </td> <td align="right"> 4.00 </td> <td align="right">   8 </td> <td align="right"> 151 </td> <td> maintenance of cell number </td> <td> CDH2, CDX2, EPAS1, ESRRB, FGF2, GNL3, VPS72, KLF4 </td> </tr>
  <tr> <td> 181 </td> <td align="center"> GO:0043523 </td> <td align="right"> 0.03 </td> <td align="right"> 2.07 </td> <td align="right"> 5.03 </td> <td align="right">  10 </td> <td align="right"> 190 </td> <td> regulation of neuron apoptotic process </td> <td> CEBPB, F2R, GRIK2, GSK3A, PRNP, SET, PINK1, BHLHB9, AKT1S1, CDC34 </td> </tr>
  <tr> <td> 182 </td> <td align="center"> GO:0071214 </td> <td align="right"> 0.01 </td> <td align="right"> 2.07 </td> <td align="right"> 7.60 </td> <td align="right">  15 </td> <td align="right"> 287 </td> <td> cellular response to abiotic stimulus </td> <td> AKT1, RAB11FIP5, GNB1, GNGT1, IFI16, IRF1, MAP3K1, TLR7, BAK1, WRN, CASP1, YBX3, CRADD, HIST3H2A, CDC25A </td> </tr>
  <tr> <td> 183 </td> <td align="center"> GO:0104004 </td> <td align="right"> 0.01 </td> <td align="right"> 2.07 </td> <td align="right"> 7.60 </td> <td align="right">  15 </td> <td align="right"> 287 </td> <td> cellular response to environmental stimulus </td> <td> AKT1, RAB11FIP5, GNB1, GNGT1, IFI16, IRF1, MAP3K1, TLR7, BAK1, WRN, CASP1, YBX3, CRADD, HIST3H2A, CDC25A </td> </tr>
  <tr> <td> 184 </td> <td align="center"> GO:0006333 </td> <td align="right"> 0.04 </td> <td align="right"> 2.07 </td> <td align="right"> 4.53 </td> <td align="right">   9 </td> <td align="right"> 171 </td> <td> chromatin assembly or disassembly </td> <td> CENPA, CENPC, ITGB3BP, CENPI, SET, TSPY4, IPO4, CENPL, HIST3H2A </td> </tr>
  <tr> <td> 185 </td> <td align="center"> GO:0007187 </td> <td align="right"> 0.04 </td> <td align="right"> 2.07 </td> <td align="right"> 4.53 </td> <td align="right">   9 </td> <td align="right"> 171 </td> <td> G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger </td> <td> GPR78, GNAT2, GNB1, HTR5A, HTR6, HTR7, GNAT3, TSHR, ADM2 </td> </tr>
  <tr> <td> 186 </td> <td align="center"> GO:2001235 </td> <td align="right"> 0.04 </td> <td align="right"> 2.07 </td> <td align="right"> 4.53 </td> <td align="right">   9 </td> <td align="right"> 171 </td> <td> positive regulation of apoptotic signaling pathway </td> <td> BCAP31, CTNNA1, GSK3A, MFF, BAK1, PINK1, ZNF205, PEA15, CRADD </td> </tr>
  <tr> <td> 187 </td> <td align="center"> GO:0051604 </td> <td align="right"> 0.01 </td> <td align="right"> 2.03 </td> <td align="right"> 7.73 </td> <td align="right">  15 </td> <td align="right"> 292 </td> <td> protein maturation </td> <td> CPA3, CR1, ASPRV1, SEC11A, IFI16, INPP5B, ANGPTL8, PRNP, BAK1, LMF1, CHAC1, BIRC7, NAA25, CASP1, BCL2L12 </td> </tr>
  <tr> <td> 188 </td> <td align="center"> GO:0072659 </td> <td align="right"> 0.03 </td> <td align="right"> 2.00 </td> <td align="right"> 5.72 </td> <td align="right">  11 </td> <td align="right"> 216 </td> <td> protein localization to plasma membrane </td> <td> CDH2, AKT1, EFR3B, EFR3A, FYB1, ABCA12, KCNJ11, PRNP, SPTBN1, ARHGAP44, CDH1 </td> </tr>
  <tr> <td> 189 </td> <td align="center"> GO:0071496 </td> <td align="right"> 0.02 </td> <td align="right"> 1.99 </td> <td align="right"> 7.33 </td> <td align="right">  14 </td> <td align="right"> 277 </td> <td> cellular response to external stimulus </td> <td> AKT1, TXN2, AOC1, IFI16, IRF1, MAP3K1, TLR7, BAK1, RALB, WRN, CASP1, CRADD, DEPDC5, NR1H4 </td> </tr>
  <tr> <td> 190 </td> <td align="center"> GO:0031330 </td> <td align="right"> 0.04 </td> <td align="right"> 1.99 </td> <td align="right"> 5.21 </td> <td align="right">  10 </td> <td align="right"> 197 </td> <td> negative regulation of cellular catabolic process </td> <td> CIRBP, CST3, AKT1, GSK3A, HNRNPD, HTR2B, YOD1, PINK1, CDK5RAP3, YBX3 </td> </tr>
  <tr> <td> 191 </td> <td align="center"> GO:0000819 </td> <td align="right"> 0.03 </td> <td align="right"> 1.97 </td> <td align="right"> 5.80 </td> <td align="right">  11 </td> <td align="right"> 219 </td> <td> sister chromatid segregation </td> <td> CENPA, CENPC, CDCA5, ITGB3BP, CDC26, CENPI, NSL1, NSMCE2, CDCA8, CENPL, BUB3 </td> </tr>
  <tr> <td> 192 </td> <td align="center"> GO:0007249 </td> <td align="right"> 0.02 </td> <td align="right"> 1.95 </td> <td align="right"> 6.93 </td> <td align="right">  13 </td> <td align="right"> 262 </td> <td> I-kappaB kinase/NF-kappaB signaling </td> <td> TRIM13, AKT1, F2R, HTR2B, IRAK4, SHISA5, TLR7, PINK1, MAP3K7, TLE1, TRAF5, CASP1, NR1H4 </td> </tr>
  <tr> <td> 193 </td> <td align="center"> GO:0019932 </td> <td align="right"> 0.02 </td> <td align="right"> 1.91 </td> <td align="right"> 7.62 </td> <td align="right">  14 </td> <td align="right"> 288 </td> <td> second-messenger-mediated signaling </td> <td> BCAP31, DMD, DMPK, GPR78, GNB1, HTR2B, HTR5A, PRNP, TSHR, UBE2B, ADM2, DGKD, HOMER2, CDC34 </td> </tr>
  <tr> <td> 194 </td> <td align="center"> GO:0051896 </td> <td align="right"> 0.05 </td> <td align="right"> 1.89 </td> <td align="right"> 5.48 </td> <td align="right">  10 </td> <td align="right"> 207 </td> <td> regulation of protein kinase B signaling </td> <td> AKR1C2, FLCN, ERBB4, AKT1, FGF2, FGFR3, PDGFRA, PINK1, FGF16, KLF4 </td> </tr>
  <tr> <td> 195 </td> <td align="center"> GO:0051146 </td> <td align="right"> 0.04 </td> <td align="right"> 1.83 </td> <td align="right"> 6.80 </td> <td align="right">  12 </td> <td align="right"> 257 </td> <td> striated muscle cell differentiation </td> <td> CDH2, HDAC5, DMD, DMPK, AKT1, KDM6B, GSK3A, LMNA, CDON, PDGFRA, ADAM12, HOMER1 </td> </tr>
  <tr> <td> 196 </td> <td align="center"> GO:0000082 </td> <td align="right"> 0.04 </td> <td align="right"> 1.81 </td> <td align="right"> 6.85 </td> <td align="right">  12 </td> <td align="right"> 259 </td> <td> G1/S transition of mitotic cell cycle </td> <td> AKT1, ESRRB, PPP6C, CENPJ, RHOU, RBL2, CCND1, E2F8, CDC7, CRADD, CDC25A, CDC34 </td> </tr>
  <tr> <td> 197 </td> <td align="center"> GO:0034976 </td> <td align="right"> 0.05 </td> <td align="right"> 1.80 </td> <td align="right"> 6.91 </td> <td align="right">  12 </td> <td align="right"> 261 </td> <td> response to endoplasmic reticulum stress </td> <td> BCAP31, TRIM13, CEBPB, DCTN1, GSK3A, LMNA, UFM1, YOD1, BAK1, CCND1, CHAC1, CDK5RAP3 </td> </tr>
   </table>
